Reliqua

Company Overview

Snapshot

Founded in January 2016 by Adam Ruimi, Nadav Kately, and Dr. Ravid Doron, Reliqua operated with 1–10 employees. The company ceased operations in December 2021.

Business overview

Reliqua developed a natural, scientifically researched herbal dietary supplement aimed at alleviating symptoms of depression and anxiety. The company's core product, RELIQUA, was based on an ancient mixture of herbs used in traditional Chinese medicine. Reliqua operated within the Health Tech & Life Sciences sector, specifically targeting the Pharmaceuticals market with a focus on mental health and well-being, serving both B2C and B2B2C business models.

Company Intelligence Q&A

What is Reliqua's primary product?

Reliqua's primary product is RELIQUA, a natural, scientifically researched herbal dietary supplement designed to alleviate symptoms of depression and anxiety.

When was Reliqua founded and by whom?

Reliqua was founded in January 2016 by co-founders Adam Ruimi, Nadav Kately, and Dr. Ravid Doron.

What is the status of Reliqua's operations?

Reliqua ceased to operate in December 2021.

What markets did Reliqua target?

Reliqua targeted the mental health and well-being markets, offering solutions for individuals suffering from depression and anxiety.

What business models did Reliqua employ?

Reliqua utilized both B2C (Business-to-Consumer) and B2B2C (Business-to-Business-to-Consumer) business models.